Colorectal Cancer

Black patients with early-onset, microsatellite-stable colorectal cancer had substantially higher tumor mutational burden than their white counterparts, according to study results.

Increased use of fecal immunochemical testing correlated with more colorectal cancer screenings and early-stage diagnoses amid the COVID-19 pandemic, according to research in JAMA Network Open.

When the COVID-19 pandemic began in the United States last year, state and local governments mandated shelter-in-place orders, which upended the practice of medicine.

Low-dose aspirin suppressed the recurrence of colorectal polyps in patients with familial adenomatous polyposis, according to research in The Lancet.

Liver transplantation may extend OS compared with portal vein embolization and liver resection for selected patients with advanced colorectal cancer liver metastases and a left-sided primary tumor, according to a study in JAMA Surgery.

The FDA approved a new cetuximab dosage regimen for the treatment of patients with KRAS wild-type, EGFR-expressing colorectal cancer or squamous cell carcinoma of the head and neck, according to a press release.

Major risk factors for CVD were associated with elevated risk for colorectal cancer, according to research published in EClinicalMedicine.

A typically high-volume endoscopy unit in Italy saw a significant reduction in procedures in the early stages of the COVID-19 pandemic, according to research presented at ESGE Days.

While hosting the live radio broadcast “Chiefs Rounds” on Sirius XM Doctor Radio, I had the privilege to have Gbenga Ogedegbe, MD, MPH, as my guest. Ogedegbe is a friend and colleague who was recently appointed to run a new endeavor at NYU Langone Health called the Institute for Excellence in Health Equity.

Colorectal Cancer Awareness Month is observed in March.